These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35127110)

  • 1. Optimal regulation of tumour-associated neutrophils in cancer progression.
    de Los Reyes AA; Kim Y
    R Soc Open Sci; 2022 Feb; 9(2):210705. PubMed ID: 35127110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model.
    Kim Y; Lee D; Lee J; Lee S; Lawler S
    PLoS One; 2019; 14(1):e0211041. PubMed ID: 30689655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical model of STAT signalling pathways in cancer development and optimal control approaches.
    Lee J; Lee D; Kim Y
    R Soc Open Sci; 2021 Sep; 8(9):210594. PubMed ID: 34631119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
    Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
    PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes
    Ohms M; Möller S; Laskay T
    Front Immunol; 2020; 11():532. PubMed ID: 32411122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression.
    Piccard H; Muschel RJ; Opdenakker G
    Crit Rev Oncol Hematol; 2012 Jun; 82(3):296-309. PubMed ID: 21798756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
    Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
    Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta 1 (TGF-beta 1) produced in tumour tissue after chemotherapy acts as a lymphokine-activated killer attractant.
    Kuramitsu Y; Nishibe M; Kobayashi M; Togashi Y; Yuan L; Takizawa M; Okada F; Hosokawa M
    Br J Cancer; 1996 Jul; 74(2):274-9. PubMed ID: 8688335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu.
    Hossain DM; Panda AK; Chakrabarty S; Bhattacharjee P; Kajal K; Mohanty S; Sarkar I; Sarkar DK; Kar SK; Sa G
    Immunology; 2015 Apr; 144(4):561-73. PubMed ID: 25284464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy via targeted TGF-β signalling blockade in T
    Li S; Liu M; Do MH; Chou C; Stamatiades EG; Nixon BG; Shi W; Zhang X; Li P; Gao S; Capistrano KJ; Xu H; Cheung NV; Li MO
    Nature; 2020 Nov; 587(7832):121-125. PubMed ID: 33087933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-TGF-β attenuates tumor growth via polarization of tumor associated neutrophils towards an anti-tumor phenotype in colorectal cancer.
    Qin F; Liu X; Chen J; Huang S; Wei W; Zou Y; Liu X; Deng K; Mo S; Chen J; Chen X; Huang Y; Liang W
    J Cancer; 2020; 11(9):2580-2592. PubMed ID: 32201528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.
    Caraglia M; Marra M; Tagliaferri P; Lamberts SW; Zappavigna S; Misso G; Cavagnini F; Facchini G; Abbruzzese A; Hofland LJ; Vitale G
    Curr Cancer Drug Targets; 2009 Aug; 9(5):690-704. PubMed ID: 19508175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils, a candidate biomarker and target for radiation therapy?
    Schernberg A; Blanchard P; Chargari C; Deutsch E
    Acta Oncol; 2017 Nov; 56(11):1522-1530. PubMed ID: 28835188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β promotes proliferation of thyroid epithelial cells in IFN-γ(-/-) mice by down-regulation of p21 and p27 via AKT pathway.
    Fang Y; Yu S; Braley-Mullen H
    Am J Pathol; 2012 Feb; 180(2):650-60. PubMed ID: 22119715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production.
    Langermans JA; Nibbering PH; Van Vuren-Van Der Hulst ME; Van Furth R
    Parasite Immunol; 2001 Apr; 23(4):169-75. PubMed ID: 11298293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.
    Fridlender ZG; Sun J; Kim S; Kapoor V; Cheng G; Ling L; Worthen GS; Albelda SM
    Cancer Cell; 2009 Sep; 16(3):183-94. PubMed ID: 19732719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
    Ballestero Fêo H; Montoya Flórez L; Yamatogi RS; Prado Duzanski A; Araújo JP; Oliveira RA; Rocha NS
    Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression.
    Biasi F; Tessitore L; Zanetti D; Cutrin JC; Zingaro B; Chiarpotto E; Zarkovic N; Serviddio G; Poli G
    Gut; 2002 Mar; 50(3):361-7. PubMed ID: 11839715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production.
    Seder RA; Marth T; Sieve MC; Strober W; Letterio JJ; Roberts AB; Kelsall B
    J Immunol; 1998 Jun; 160(12):5719-28. PubMed ID: 9637480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis.
    Garrison K; Hahn T; Lee WC; Ling LE; Weinberg AD; Akporiaye ET
    Cancer Immunol Immunother; 2012 Apr; 61(4):511-21. PubMed ID: 21971588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.